STERIS plc
—- Market cap
- $21.44B
- Debt
- +$1.93B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 92% equity / 8% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $21.44B · View financials
Snapshot Sep 8, 2026, 1:46 PM ET
FY 2025 · Mkt cap
Decision snapshot: STE stock price at premium vs EXC $219.92 current versus $129.45 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EXC's multiple
Implied fair value · at STE's multiple
Snapshot Sep 8, 2026, 1:48 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: STE FY 2026 (ended Mar 31, 2026) · EXC FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 92% equity / 8% debt
Capital structure 47% equity / 53% debt · EV / Revenue 3.94x · EV / EBITDA 11.45x
EXC carries the larger enterprise value at $95.65B against $23.37B; STE trades on the lower EV / Revenue multiple (3.94x vs 3.94x); EXC on the lower EV / EBITDA (11.45x vs 15.27x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
STERIS plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
EXELON CORPORATION · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.27x
1.77x
Net debt / EBITDA
Leverage against operating earnings
—
6.04x
Cash and equivalents
Liquid reserves on the balance sheet
—
$626.00M
Total debt
Interest-bearing obligations outstanding
$1.93B
$51.09B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Johnson & Johnson
STE vs JNJ
BAXTER INTERNATIONAL INC
STE vs BAX
BECTON DICKINSON & CO
STE vs BDX
ZIMMER BIOMET HOLDINGS, INC.
STE vs ZBH
SOUTHERN CO
STE vs SO
ENTERGY CORP /DE/
STE vs ETR
CONSOLIDATED EDISON INC
STE vs ED
Duke Energy Corporation
STE vs DUK
AMERICAN ELECTRIC POWER CO INC
STE vs AEP
DOMINION ENERGY, INC
STE vs D
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.